Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-07-25 Purchase |
2024-07-29 4:18 pm |
Regulus Therapeutics Inc. | RGLS | Collier Kathryn J Director |
4,000 | $1.82 | $7,280 | 6,740 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-05-20 Option Award |
2024-05-21 4:22 pm |
N/A 2034-05-19 |
Regulus Therapeutics Inc. | RGLS | Collier Kathryn J Director |
60,000 | $0 | 60,000 (Direct) |
View |
| 2024-05-16 Option Award |
2024-05-17 5:16 pm |
N/A 2034-05-15 |
Regulus Therapeutics Inc. | RGLS | Collier Kathryn J Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2023-08-10 Option Award |
2023-08-14 4:40 pm |
N/A 2033-08-09 |
Regulus Therapeutics Inc. | RGLS | Collier Kathryn J Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2023-06-13 Option Award |
2023-06-13 4:47 pm |
N/A 2033-06-12 |
Regulus Therapeutics Inc. | RGLS | Collier Kathryn J Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-10 4:24 pm |
N/A 2032-06-09 |
Regulus Therapeutics Inc. | RGLS | Collier Kathryn J Director |
90,000 | $0 | 90,000 (Direct) |
View |
| 2021-06-14 Option Award |
2021-06-15 4:40 pm |
N/A 2031-06-13 |
Regulus Therapeutics Inc. | RGLS | Collier Kathryn J Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2020-06-17 Option Award |
2020-06-19 4:38 pm |
N/A 2030-06-16 |
Regulus Therapeutics Inc. | RGLS | Collier Kathryn J Director |
23,250 | $0 | 23,250 (Direct) |
View |